PSYCHIATRIC RESEARCH UPDATESThe Daily Psych

bt_bb_section_bottom_section_coverage_image

https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_01.png?fit=75%2C84&ssl=1

https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1

https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1

FDA Approves At-Home tDCS — But Should It Have?

Depression Neuromodulation/TMS Research

FDA Approves At-Home tDCS — But Should It Have?

April 25, 2026by Chris Aiken, MD2

Censorship, Bias, and Autism

Autism Research Supplements

Censorship, Bias, and Autism

April 10, 2026by Chris Aiken, MD0

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

Antipsychotics Research Schizophrenia and Psychosis

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

Two GLP-1 Agonists Fail in Dementia

Dementia GLP1 Agonists Research

Two GLP-1 Agonists Fail in Dementia

January 25, 2026by Chris Aiken, MD0

Brexpiprazole (Rexulti) in PTSD

Antipsychotics Medications PTSD Research Top Research

Brexpiprazole (Rexulti) in PTSD

September 21, 2025by Chris Aiken, MD0